Pancreatic Cancer Metastasis: Are we being Pre-EMTed?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|10|1249-1255

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.10, 2015-03, pp. : 1249-1255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer

By Kilian Maik   Gregor Jan   Heukamp Ina   Braumann Chris   Guski Hans   Schimke Ingolf   Walz Martin   Jacobi Christoph   Wenger Frank  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite

Glufosfamide promising for pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Emerging drugs in pancreatic cancer

By Ducreux Michel   Boige Valérie   Malka David  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 73-89

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Metastatic Pancreatic Cancer

By Ko Andrew H.   Tempero Margaret A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 5, 2005-09 ,pp. : 627-636

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Depression and Pancreatic Cancer

By Boyd Andrew D.   Riba Michelle  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 113-116

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite